Patient Registry Software Market By Type, Disease Areas & End User- Global Industry Analysis And Forecast To 2023

Published On : June 2018 Pages : 190 Category: Healthcare IT Report Code : HC06956

Industry Outlook and Trend Analysis

The Patient Registry Software Market was worth USD 0.57 billion in 2014 and is expected to reach approximately USD 1.61 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 12.22% during the forecast period. Patient registries are the mechanized databases that contain individual, medicinal, social, and money related information being accounted for by human services experts and patients. For uncommon or unending ailments, registries can give indispensable epidemiological information, for example, occurrence and predominance, manifestations, and seriousness of the sickness to specialists and medicinal services experts. Because of the nonstop development of endless illnesses, populace and sickness administration is profoundly required, which thus drives the general interest for understanding registry programming. The developing interest for patient registry programming has prompted the rise of patient registry programming sellers around the globe, which has added to the development of market estimate all around.

Drivers & Restrains

The worldwide patient pool of constantly sick is on the ascent over numerous maladies. This developing patient number is making an appeal for patient registry programming over the world. The product enables clients to create long haul documentations of patient narratives which are to a great degree valuable for a doctor in dealing with his or her pool of patients with incessant illnesses. Key patient registry programming players also get bolster from governments through different activities went for enhancing the proficiency of the therapeutic administrations that are at present accessible. In the long run these activities can bestow advantages to specialists, for example, presentation to a more noteworthy pool of patients, enhance quiet recuperation shots, lower or even kill direction for living relate wellbeing dangers, and keep up lasting records of patients with interminable diseases.

Regional Outlook and Trend Analysis

North America is expected to witness considerable growth over the forecast period. The patient registry programming suppliers in North America pick up popularity for their products and administrations through the high level of patients experiencing unending maladies, alongside the nearness of achievable repayment approaches. Also, the greater part of the players situated in North America hold a place in an exceptionally propelled medicinal services foundation that is prepared to acquire and actualize present day administration systems. North America clients likewise demonstrate a higher rate of awareness towards medicinal services patterns and the utilization of patient registry programming. The vast majority of all, the development of mHealth patterns is driving the interest for patient registry software in North America.

Competitive Insights

The leading players in the market are Quintiles, Inc., PatientCrossroads, Evado Clinical Solution, and Dacima Software, Inc. and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Patient Registry Software Market is segmented as follows-

By Type:

  • Public Domain Registry Software
  • Commercial Registry Software

By Disease Areas:

  • Diabetes Registry
  • Cardiovascular Registry
  • Cancer Registry
  • Rare Disease/Orphan Disease Registry
  • Other Chronic Disease Registry

By End User:

  • Government
  • Commercial

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Patient Registry Software Market, By Type, Estimates and Forecast, 2014-2023($Billion)

o    Public Domain Registry Software

o    Commercial Registry Software

·         Patient Registry Software Market, By Disease Areas, Estimates and Forecast, 2014-2023($Billion)

o    Diabetes Registry

o    Cardiovascular Registry

o    Cancer Registry

o    Rare Disease/Orphan Disease Registry

o    Other Chronic Disease Registry

·         Patient Registry Software Market, By End User, Estimates and Forecast, 2014-2023($Billion)

o    Government

o    Commercial

·         Patient Registry Software Market, By Region, Estimates and Forecast, 2014-2023($Billion)

o    North America

§  North America Patient Registry Software Market, By Country

o    U.S. Patient Registry Software Market

o    Canada Patient Registry Software Market

o    Mexico Patient Registry Software Market

o    Europe

§  Europe Patient Registry Software Market, By Country

o    Germany Patient Registry Software Market

o    UK Patient Registry Software Market

o    France Patient Registry Software Market

o    Russia Patient Registry Software Market

o    Italy Patient Registry Software Market

o    Rest of Europe Patient Registry Software Market

o    Asia-Pacific

§  Asia-Pacific Patient Registry Software Market, By Country

o    China Patient Registry Software Market

o    Japan Patient Registry Software Market

o    South Korea Patient Registry Software Market

o    India Patient Registry Software Market

o    Southeast Asia Patient Registry Software Market

o    Rest of Asia-Pacific Patient Registry Software Market

o    South America

§  South America Patient Registry Software Market

o    Brazil Patient Registry Software Market

o    Argentina Patient Registry Software Market

o    Columbia Patient Registry Software Market

o    South Africa Patient Registry Software Market

o    Rest of South America Patient Registry Software Market

o    Middle East and Africa

§  Middle East and Africa Patient Registry Software Market

o    Saudi Arabia Patient Registry Software Market

o    UAE Patient Registry Software Market

o    Egypt Patient Registry Software Market

o    Nigeria Patient Registry Software Market

o    South Africa Patient Registry Software Market

o    Rest of MEA Patient Registry Software Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Patient Registry Software Market, By Type

5.1.       Introduction

5.2.       Global Patient Registry Software Revenue and Market Share by Type (2014-2018)

5.2.1.  Global Patient Registry Software Revenue and Revenue Share by Type (2014-2018)

5.3.       Gastrointestinal and Metabolic Disorders

5.3.1.  Global Gastrointestinal and Metabolic Disorders Revenue and Growth Rate (2014-2018)

5.4.       Public Domain Registry Software

5.4.1.  Global Public Domain Registry Software Revenue and Growth Rate (2014-2018)

5.5.       Commercial Registry Software

5.5.1.  Global Commercial Registry Software Revenue and Growth Rate (2014-2018)

6.       Patient Registry Software Market, By Disease Areas

6.1.       Introduction

6.2.       Global Patient Registry Software Revenue and Market Share by Disease Areas (2014-2018)

6.2.1.  Global Patient Registry Software Revenue and Revenue Share by Disease Areas (2014-2018)

6.3.       Diabetes Registry

6.3.1.  Global Diabetes Registry Revenue and Growth Rate (2014-2018)

6.4.       Cardiovascular Registry

6.4.1.  Global Cardiovascular Registry Revenue and Growth Rate (2014-2018)

6.5.       Cancer Registry

6.5.1.  Global Cancer Registry Revenue and Growth Rate (2014-2018)

6.6.       Rare Disease/Orphan Disease Registry

6.6.1.  Global Rare Disease/Orphan Disease Registry Revenue and Growth Rate (2014-2018)

6.7.       Other Chronic Disease Registry

6.7.1.  Global Other Chronic Disease Registry Revenue and Growth Rate (2014-2018)

7.       Patient Registry Software Market, By End User

7.1.       Introduction

7.2.       Global Patient Registry Software Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Patient Registry Software Revenue and Revenue Share by End User (2014-2018)

7.3.       Government

7.3.1.  Global Government Revenue and Growth Rate (2014-2018)

7.4.       Commercial

7.4.1.  Global Commercial Revenue and Growth Rate (2014-2018)

8.       Patient Registry Software Market, By Region

8.1.       Introduction

8.2.       Global Patient Registry Software Revenue and Market Share by Regions

8.2.1.  Global Patient Registry Software Revenue by Regions (2014-2018)

8.3.       North America Patient Registry Software by Countries

8.3.1.  North America Patient Registry Software Revenue and Growth Rate (2014-2018)

8.3.2.  North America Patient Registry Software Revenue by Countries (2014-2018)

8.3.3.  North America Patient Registry Software Revenue (Million USD) by Countries (2014-2018)

8.3.4.  U.S.

8.3.4.1.    United States Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Canada

8.3.5.1.    Canada Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.6.  Mexico

8.3.6.1.    Mexico Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.       Europe Patient Registry Software by Countries

8.4.1.  Europe Patient Registry Software Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Patient Registry Software Revenue by Countries (2014-2018)

8.4.3.  Europe Patient Registry Software Revenue (Million USD) by Countries (2014-2018)

8.4.4.  Germany

8.4.4.1.    Germany Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.    UK Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  France

8.4.6.1.    France Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Russia

8.4.7.1.    Russia Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Italy

8.4.8.1.    Italy Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.9.  Rest of Europe

8.4.9.1.    Rest of Europe Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific Patient Registry Software Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Patient Registry Software Revenue by Countries (2014-2018)

8.5.3.  Asia-Pacific Patient Registry Software Revenue (Million USD) by Countries (2014-2018)

8.5.4.  China

8.5.4.1.    China Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Japan

8.5.5.1.    Japan Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.2.     

8.5.6.  Korea

8.5.6.1.    Korea Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  India

8.5.7.1.    India Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Southeast Asia

8.5.8.1.    Southeast Asia Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.9.  Rest of Asia-Pacific

8.5.9.1.    Rest of Asia-Pacific Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.       South America

8.6.1.  South America Patient Registry Software Revenue and Growth Rate (2014-2018)

8.6.2.  South America Patient Registry Software Revenue by Countries (2014-2018)

8.6.3.  South America Patient Registry Software Revenue (Million USD) by Countries (2014-2018)

8.6.4.  Brazil

8.6.4.1.    Brazil Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Argentina

8.6.5.1.    Argentina Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Columbia

8.6.6.1.    Columbia Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.7.  Rest of South America

8.6.7.1.    Rest of South America Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa Patient Registry Software Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Patient Registry Software Revenue by Countries (2014-2018)

8.7.3.  Middle East and Africa Patient Registry Software Revenue (Million USD) by Countries (2014-2018)

8.7.4.  Saudi Arabia

8.7.4.1.    Saudi Arabia Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  United Arab Emirates

8.7.5.1.    United Arab Emirates Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Egypt

8.7.6.1.    Egypt Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  Nigeria

8.7.7.1.    Nigeria Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  South Africa

8.7.8.1.    South Africa Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.    Rest of Middle East and Africa Patient Registry Software Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.       Global Vision Technologies, Inc.

9.1.1.  Business Overview

9.1.2.  Type Portfolio

9.1.3.  Strategic Developments

9.1.4.  Revenue and Market Share

9.2.       Quintiles Inc.

9.2.1.  Business Overview

9.2.2.  Type Portfolio

9.2.3.  Strategic Developments

9.2.4.  Revenue and Market Share

9.3.       Dacima Software Inc.

9.3.1.  Business Overview

9.3.2.  Type Portfolio

9.3.3.  Strategic Developments

9.3.4.  Revenue and Market Share

9.4.       PatientCrossroads

9.4.1.  Business Overview

9.4.2.  Type Portfolio

9.4.3.  Strategic Developments

9.4.4.  Revenue and Market Share

9.5.       Evado eClinical Solutions

9.5.1.  Business Overview

9.5.2.  Type Portfolio

9.5.3.  Strategic Developments

9.5.4.  Revenue and Market Share

10.   Global Patient Registry Software Market Competition, by Manufacturer

10.1.    Global Patient Registry Software Revenue and Market Share by Manufacturer (2016-2017)

10.2.    Global Patient Registry Software Price by Region (2016-2017)

10.3.    Top 5 Patient Registry Software Manufacturer Market Share

10.4.    Market Competition Trend

11.   Patient Registry Software Market Forecast (2018-2023)

11.1.    Global Patient Registry Software Revenue (Millions USD) and Growth Rate (2018-2023)

11.2.    Patient Registry Software Market Forecast by Regions (2018-2023)

11.2.1.      North America Patient Registry Software Market Forecast (2018-2023)

11.2.1.1. United States Patient Registry Software Market Forecast (2018-2023)

11.2.1.2. Canada Patient Registry Software Market Forecast (2018-2023)

11.2.1.3. Mexico Patient Registry Software Market Forecast (2018-2023)

11.2.2.      Europe Patient Registry Software Market Forecast (2018-2023)

11.2.2.1. Germany Patient Registry Software Market Forecast (2018-2023)

11.2.2.2. United Kingdom Patient Registry Software Market Forecast (2018-2023)

11.2.2.3. France Patient Registry Software Market Forecast (2018-2023)

11.2.2.4. Russia Patient Registry Software Market Forecast (2018-2023)

11.2.2.5. Italy Patient Registry Software Market Forecast (2018-2023)

11.2.2.6. Rest of the Europe Patient Registry Software Market Forecast (2018-2023)

11.2.3.      Asia-Pacific Patient Registry Software Market Forecast (2018-2023)

11.2.3.1. China Patient Registry Software Market Forecast (2018-2023)

11.2.3.2. Japan Patient Registry Software Market Forecast (2018-2023)

11.2.3.3. Korea Patient Registry Software Market Forecast (2018-2023)

11.2.3.4. India Patient Registry Software Market Forecast (2018-2023)

11.2.3.5. Southeast Asia Patient Registry Software Market Forecast (2018-2023)

11.2.3.6. Rest of Asia-Pacific Patient Registry Software Market Forecast (2018-2023)

11.2.4.      South America Patient Registry Software Market Forecast (2018-2023)

11.2.4.1. Brazil Patient Registry Software Market Forecast (2018-2023)

11.2.4.2. Argentina Patient Registry Software Market Forecast (2018-2023)

11.2.4.3. Columbia Patient Registry Software Market Forecast (2018-2023)

11.2.4.4. Rest of South America Patient Registry Software Market Forecast (2018-2023)

11.2.5.      Middle East and Africa Patient Registry Software Market Forecast (2018-2023)

11.2.5.1. Saudi Arabia Patient Registry Software Market Forecast (2018-2023)

11.2.5.2. UAE Patient Registry Software Market Forecast (2018-2023)

11.2.5.3. Egypt Patient Registry Software Market Forecast (2018-2023)

11.2.5.4. Nigeria Patient Registry Software Market Forecast (2018-2023)

11.2.5.5. South Africa Patient Registry Software Market Forecast (2018-2023)

11.2.5.6. Rest of MEA Patient Registry Software Market Forecast (2018-2023)

11.3.    Patient Registry Software Market Forecast by Type (2018-2023)

11.3.1.      Global Patient Registry Software Revenue Forecast by Type (2018-2023)

11.3.2.      Global Patient Registry Software Revenue Market Share Forecast by Type (2018-2023)

11.4.    Patient Registry Software Market Forecast by Disease Areas (2018-2023)

11.4.1.      Global Patient Registry Software Revenue Forecast by Disease Areas (2018-2023)

11.4.2.      Global Patient Registry Software Revenue Market Share Forecast by Disease Areas (2018-2023)

11.5.    Patient Registry Software Market Forecast by Disease Areas (2018-2023)

11.5.1.      Global Patient Registry Software Revenue Forecast by Disease Areas (2018-2023)

11.5.2.      Global Patient Registry Software Revenue Market Share Forecast by Disease Areas (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Patient Registry Software Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*